Core Viewpoint - The glutamic acid market in China is experiencing growth driven by increasing food consumption, with a projected demand of 262.36 million tons in 2023, but is expected to decline to 256.53 million tons in 2024 due to macroeconomic factors [1][11]. Industry Overview - Glutamic acid is a significant food additive, primarily used as a flavor enhancer in the food industry, with over 60% of its demand coming from this sector [9][11]. - The market size for glutamic acid reached 236.67 billion yuan in 2023, but is forecasted to decrease to 202.97 billion yuan in 2024 [1][11]. Supply Chain - The upstream supply chain includes suppliers of raw materials like corn and starch, as well as auxiliary materials and production equipment [6]. - The midstream involves the production of glutamic acid, while the downstream applications span food, feed, and pharmaceuticals [6]. Competitive Landscape - The glutamic acid market in China is characterized by an oligopolistic structure, with leading companies like Fujian Group, Meihua Biological Technology, and Yipin Biological dominating the market, holding over 80% of the market share [15][18]. - Fujian Group reported a total revenue of 27.76 billion yuan in 2024, with a gross profit of 5.057 billion yuan [18]. - Meihua Biological Technology achieved a total revenue of 25.07 billion yuan in 2024, with a significant portion coming from animal nutrition amino acids [20]. Development Trends - There is a growing consumer preference for high-purity and low-sodium glutamic acid products, with L-glutamic acid and polyglutamic acid expected to be key growth areas [22]. - The industry is moving towards sustainable production practices, focusing on reducing energy consumption and waste, and improving water recycling and resource recovery [22].

Core Viewpoint - The amino acid market in China is experiencing growth driven by downstream sectors such as feed, food processing, pharmaceuticals, and health products, with a projected demand of 575.08 million tons in 2023, but expected to decline to 561.52 million tons in 2024 due to macroeconomic factors [1][19]. Overview - Amino acids are essential components of proteins and are widely used in various industries, including feed, food, and pharmaceuticals [2][6]. - The classification of amino acids includes essential, semi-essential, and non-essential types, with specific applications based on their properties [3][4]. Market Demand and Trends - The demand for amino acids is projected to decrease in 2024, with the market size expected to drop to 60.862 billion yuan, where glutamic acid accounts for 33.35%, lysine for 32.79%, threonine for 10.11%, methionine for 13.73%, and tryptophan for 2.15% [1][19]. - There is a growing consumer preference for natural and healthy products, which is expected to boost the demand for green and environmentally friendly amino acids and derivatives [1][19]. Industry Development - The amino acid industry in China has evolved from extraction methods to microbial fermentation, significantly reducing production costs and increasing efficiency [6][7]. - The industry is witnessing consolidation, with larger companies acquiring smaller ones to enhance market share and competitiveness [7][8]. Market Policies - Recent policies in China support technological innovation and industrial upgrades in the amino acid sector, promoting the use of amino acids in feed to ensure supply safety [10][12]. Industry Chain - The upstream of the amino acid industry includes suppliers of raw materials like corn, soybeans, and wheat, while the downstream encompasses applications in feed, food processing, pharmaceuticals, and health products [13][15]. - The feed sector is the largest market for amino acids, accounting for over 60% of demand, with significant growth in industrial feed production [17][19]. Competitive Landscape - The amino acid market in China is concentrated among leading companies such as Meihua Biological Technology Group, Fujian Fufeng Group, and Zhejiang New Hope Liuhe, which dominate the market [21][25]. - Meihua Biological is the largest producer of lysine, while Fufeng Group leads in MSG production, indicating a competitive environment with significant market players [21][27]. Future Trends - There is an increasing demand for high-purity amino acids in pharmaceuticals and cosmetics, supported by national policies favoring green production methods [29][30].

Group 1 - The company, 阜丰集团 (00546.HK), announced that its board of directors will hold a meeting on August 28, 2025, to consider and approve various matters [1] - The meeting will include the review of the unaudited interim results for the company and its subsidiaries for the period ending June 30, 2025 [1] - The board will also consider the declaration of an interim dividend, if applicable [1]

承董事會命 阜豐集團有限公司 董事長 李學純 （於開曼群島註冊成立的有限公司） （股份代號：546） 董事會會議日期 阜 豐 集 團 有 限 公 司（「本公司」）董 事 會（「董事會」）謹 此 宣 佈，本 公 司 董 事 會 將 於 二 零 二 五 年 八 月 二 十 八 日（星 期 四）舉 行 會 議，籍 以 考 慮 及 批 准 之 事 項，其 中 包 括 本 公 司 及 其 附 屬 公 司 截 至 二 零 二 五 年 六 月 三 十 日 止 的 未 經 審 核 中 期 業 績， 以 及 考 慮 派 付 中 期 股 息（如 有）。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 Fufeng Group Limited 阜豐集團有限公司 香 港，二 零 二 五 年 八 月 十 八 日 於 本 公 告 日 期，本 公 司 的 執 行 董 事 為 李 學 純 先 生、李 德 衡 先 生 及 李 廣 ...

Summary of Key Points Core Viewpoint - The report highlights the top short-selling stocks in Hong Kong, indicating significant short-selling activity in companies like New World Development, Hong Kong Exchanges, and BYD, with notable short-selling ratios and amounts [1][2]. Short-Selling Ratios - New World Development (80016) has the highest short-selling ratio at 100.00% - Hong Kong Exchanges (80388) follows with a short-selling ratio of 94.27% - BYD (81211) has a short-selling ratio of 94.13% [1][2]. Short-Selling Amounts - Alibaba (09988) leads in short-selling amount with HKD 1.546 billion - Tencent (00700) has a short-selling amount of HKD 1.265 billion - Xiaomi (01810) follows with HKD 1.188 billion [1][2]. Deviation Values - Hong Kong Exchanges (80388) has the highest deviation value at 54.37% - New World Development (80016) has a deviation value of 41.90% - Alibaba (89988) shows a deviation value of 39.84% [1][2].

Summary of Key Points Core Viewpoint - The report highlights the top short-selling stocks in the market, indicating significant investor sentiment against these companies, with notable short-selling ratios and amounts for specific stocks [1][2]. Group 1: Top Short-Selling Ratios - Anta Sports (82020) has the highest short-selling ratio at 100.00% with a short-selling amount of 97,800 CNY [2]. - China National Offshore Oil Corporation (80883) follows with a short-selling ratio of 90.59% and a short-selling amount of 1,305,000 CNY [2]. - Tencent Holdings (00700) has a short-selling ratio of 87.99% with a short-selling amount of 1,125,000 CNY [2]. Group 2: Top Short-Selling Amounts - Meituan (03690) leads in short-selling amount with 1.136 billion CNY and a short-selling ratio of 23.98% [2]. - Xiaomi Group (01810) has a short-selling amount of 1.04 billion CNY and a short-selling ratio of 16.20% [2]. - Tencent Holdings (00700) also appears in this category with a short-selling amount of 1.007 billion CNY and a short-selling ratio of 15.29% [2]. Group 3: Top Short-Selling Deviation Values - Tencent Holdings (80700) has the highest deviation value at 45.57%, indicating a significant difference from its average short-selling ratio over the past 30 days [2]. - China National Offshore Oil Corporation (80883) has a deviation value of 42.14% [2]. - China State Construction International (03311) shows a deviation value of 34.50% [2].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 阜豐集團有限公司 呈交日期: 2025年8月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00546 | 說明 | 不適用 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | II. 已發行股份及/或庫存股份變動 本月 ...

Group 1 - The core viewpoint of the news is the performance and characteristics of the Hong Kong Dividend Low Volatility ETF (520890), which has seen a significant decrease in both shares and scale in 2024 [1][2] - As of August 4, 2024, the fund's latest shares were 56.508 million, with a scale of 80.0775 million yuan, reflecting a 54.06% decrease in shares and a 45.28% decrease in scale compared to December 31, 2024 [1] - The fund's management fee is 0.50% annually, and the custody fee is 0.10% annually, with a performance benchmark based on the Hang Seng Hong Kong Stock Connect High Dividend Low Volatility Index [1] Group 2 - The current fund manager, Li Qian, has managed the fund since its inception on September 4, 2024, achieving a return of 41.71% during her tenure [1] - The ETF's recent trading activity shows a cumulative transaction amount of 140 million yuan over the last 20 trading days, with an average daily transaction amount of 7.0048 million yuan [1] - The top holdings of the ETF include Shougang Resources (3.83%), Far East Horizon (3.69%), and Chongqing Rural Commercial Bank (3.27%), among others, with detailed holdings and market values provided [2]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 阜豐集團有限公司 呈交日期: 2025年8月1日 第 2 頁 共 10 頁 v 1.1.1 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00546 | 說明 | 不適用 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.1 | HKD | | 1,000,000,000 | ...

Group 1: Hong Kong Stock Market Movements - Jin Jing New Energy (01783) rose over 4.5% as the Hang Seng Index company is set to release its mid-year review results on August 22, with changes effective from September 8 [1] - Paper stocks in Hong Kong continued to rise, with Nine Dragons Paper (02689.HK) increasing over 7%, recording five consecutive gains, while Lee & Man Paper (02314.HK) rose about 5% [1] - Airline stocks saw significant gains, with China National Aviation (0753.HK) up over 7%, driven by the Civil Aviation Administration's emphasis on enhancing the industry’s competitive landscape [1] - Renrui Talent (06919) surged over 19% after announcing a positive earnings forecast, expecting revenue of approximately RMB 2.49 billion to 2.69 billion for the year ending June 30, 2025, representing a year-on-year growth of 21.1% to 30.8% [1] Group 2: Other Notable Stock Movements - China Antibody-B (03681) increased over 8% after entering into subscription agreements for the issuance of 182 million new shares at a subscription price of HKD 2.03 per share [2] - Fufeng Group (00546) rose over 4% with an expected net profit of RMB 1.74 billion for the first half of the year, a 67% increase year-on-year, attributed to higher sales and lower raw material costs [2] - Cao Cao Travel (02643) gained over 4%, reaching a new high following a strategic partnership with a leading commercial aerospace company [2] - NIO-SW (09866) rose over 8%, with a cumulative increase of over 40% in the month [2] Group 3: US Stock Market Highlights - Kohl's (KSS.US) saw a dramatic increase of nearly 90%, becoming a popular "meme stock" among retail investors, closing at $14.34, up 37.62% [3] - Daqo New Energy (DQ.US) closed at $24.60, with a rise of 16.75%, as silicon material prices have been on the rise, with an increase of 25-35% recently [3] - General Motors (GM.US) stock fell by 8.12% to $48.89, with the CFO indicating potential tariff impacts of up to $5 billion this year [3] - The Nasdaq Golden Dragon China Index rose 1.35%, with notable gains in Chinese concept stocks, including PONY.US up 8.62% and NIO.US up 10.84% [3] Group 4: Additional Stock Movements - Faraday Future (FFAI.US) surged over 43% after receiving a non-binding order for 1,000 vehicles valued at up to $100 million [4] - Most new energy vehicle stocks rose, with Lucid Group (LCID.US) closing at $3.13, an increase of about 11% [4] - Circle (CRCL.US) fell by 8.23% after a downgrade from "neutral" to "sell" by Compass Point Research [4] - Replimune (REPL.US) dropped 77% after the FDA rejected its application for a combination therapy for advanced melanoma, citing insufficient evidence [4]